McAdamLP, O'HanlanMA, BluestoneR, PearsonCM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine, 1976; 55(3):193–215.
2.
ErnstA, RafeqS, BoiselleP, SungA, ReddyC, MichaudG, et al. Relapsing polychondritis and airway involvement. Chest, 2009; 135(4):1024–1030.
3.
MichetCJJr, McKennaCH, LuthraHS, O'FallonWM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med, 1986; 104(1):74–78.
4.
DamianiJM, LevineHL. Relapsing polychondritis–report of ten cases. Laryngoscope, 1979; 89(6 Pt 1):929–946.
EngJ, SabanathanS. Airway complications in relapsing polychondritis. Ann Thorac Surg, 1991; 51(4):686–692.
9.
SarodiaBD, DasguptaA, MehtaAC. Management of airway manifestations of relapsing polychondritis: case reports and review of literature. Chest, 1999; 116(6):1669–1675.
10.
DunneJA, SabanathanS. Use of metallic stents in relapsing polychondritis. Chest, 1994; 105(3):864–867.
11.
CazabonS, OverK, ButcherJ. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis. Eye, 2005; 19(2):222–224.
12.
SubrahmanyamP, BalakrishnanC, DasguptaB. Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia. Scand J Rheumatol, 2008; 37(3):239–240.
13.
EngAM, ReddyVB. Relapsing polychondritis responding to colchicine. Int J Dermatol, 1994; 33(6):448–449.
14.
ParkJ, GowinKM, SchumacherHRJr. Steroid sparing effect of methotrexate in relapsing polychondritis. J Rheumatol, 1996; 23(5):937–938.
15.
Hoang-XaunT, FosterCS, RiceBA. Scleritis in relapsing polychondritis. Response to therapy. Ophthalmology, 1990; 97(7):892–898.
16.
VounotrypidisP, SakellariouGT, ZisopoulosD, BerberidisC. Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra). Rheumatology, 2006; 45(4):491–492.
